Market News & Trends
Catalent Announces Organizational Restructuring to Support Customer Demand for Fast, Integrated Biologics Development
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently announced key organizational changes…
Porton Pharma Solutions & Codexis Launch Global Partnership
Codexis, Inc and Porton Pharma Solutions, Ltd. recently announced a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and active…
Emisphere Amends License Agreement with Novo Nordisk; Will Receive $7 Million
Emisphere Technologies, Inc. recently announced that it has amended its existing 2015 Development and License Agreement with Novo Nordisk A/S for the development and commercialization of…
Roquette: Bringing New Solutions for Biotherapeutics
Protein stabilization is a critical challenge facing biotherapeutic formulators due to a multitude of destabilizing forces and pathways. The complexity and natural propensity of proteins…
Noramco & SPI Pharma Sign Agreement to Develop Ready-to-Implement, Patient-Friendly Formulations
Noramco and SPI Pharma recently announced the two companies have signed an agreement to develop and license a set of “value-added” formulation packages for global…
Catalent to Invest $5 Million at Somerset Site to Create New Drug Development & Modified Release Center of Excellence
Catalent Pharma Solutions recently announced it plans to invest $5 million in the creation of a new drug development center of excellence (CoE) at its…
New Preclinical Studies Reinforce the Potential for Heightened Anti-Cancer Activity of Combination Therapies Based on Immunovaccine’s Proprietary Delivery Platform
Immunovaccine Inc. recently announced that it presented new research on its T-cell activating platform at the American Association for Cancer Research (AACR) Annual Meeting 2018.…
Organovo Achieves Key Development Milestones
Organovo Holdings, Inc. recently announced that along with its collaborators, it has achieved several breakthrough capabilities for its 3D bioprinted tissues. At the International Liver Congress,…
Kineta to Collaborate on the Development of a Novel Non-Opioid Pain Therapy With Genentech
Kineta Chronic Pain, LLC, a subsidiary of Kineta, Inc., recently announced it has entered into an exclusive option and license agreement with Genentech, a member…
Foamix Announces $16 Million Investment by OrbiMed
Foamix Pharmaceuticals Ltd. recently announced it has raised aggregate gross proceeds of approximately $16 million through a direct registered offering of its ordinary shares to OrbiMed. On…
Synteract Repositions Itself With Centers of Therapeutic Development & Unveils Updated Brand Platform
Synteract recently announced the creation of therapeutic centers of development that include some of the most progressive in the biopharma industry: oncology, especially leading-edge immunotherapy…
Carpe Secures $2.3 Million to Fight Hyperhidrosis
Carpe, a skincare startup offering over-the-counter relief for excessive hand and foot sweating to the estimated 365 million hyperhidrosis sufferers worldwide, recently announced it has…
WuXi AppTec Expands Site in the United States for Drug Development Testing Services
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, recently announced the opening of its expanded Laboratory Testing Division…
Provectus Biopharmaceuticals Expands Global Patent Portfolio
Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company developing PV-10 as the first small molecule oncolytic immunotherapy for solid tumor cancers, recently announced that the Japan Patent…
Ubiquigent & Forma Therapeutics Enter Exclusive R&D Collaboration
Ubiquigent Limited recently announced it has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for the design and development of novel deubiquitylase…
Syntel Partners With Esko for Life Sciences Labeling & Packaging Solutions
Syntel, Inc. recently announced it has signed a strategic partnership with Esko, a leading provider of prepress software and hardware for labeling and packaging. Headquartered…
Nutriband Acquires 4P Therapeutics; Creates Transdermal & Topical Arm
Nutriband Inc. recently announced the acquisition of 4P Therapeutics Inc. on April 5, 2018. Nutriband has acquired 100% interest in 4P Therapeutics for a total…
Aclaris Therapeutics Partners With Cipher Pharmaceuticals
Aclaris Therapeutics, Inc. recently announced it has licensed the Canadian rights to commercialize A-101 40% topical solution for the treatment of raised seborrheic keratoses (A-101…
BriaCell Presents Encouraging Clinical Data
BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company with a proprietary targeted immunotherapy technology, recently announced it presented a late-breaking poster presentation at the Annual Meeting…
Wave Life Sciences & Deep Genomics Form Collaboration
Wave Life Sciences Ltd. and Deep Genomics Inc. recently announced the formation of a collaboration to identify novel therapies to be developed by Wave for…
